| Not Yet Recruiting | Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata NCT06430190 | Zhangyu Bu | N/A |
| Completed | Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study NCT06297187 | Integra LifeSciences Corporation | — |
| Active Not Recruiting | Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women NCT06197802 | Xiamen University | — |
| Completed | Intralesional HPV Vaccine for Condylomata NCT05087849 | University of California, San Francisco | Phase 1 / Phase 2 |
| Active Not Recruiting | An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Ye NCT05056402 | Xiamen University | Phase 3 |
| Completed | Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Col NCT04782895 | Xiamen University | Phase 3 |
| Active Not Recruiting | Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,5 NCT04537156 | Xiamen University | Phase 3 |
| Unknown | Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genit NCT03853785 | Assiut University | Phase 3 |
| Completed | A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts NCT03981822 | Verrica Pharmaceuticals Inc. | Phase 2 |
| Completed | Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) NCT03935204 | Xiamen University | Phase 2 |
| Completed | Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) NCT03813940 | Xiamen University | Phase 1 |
| Completed | Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females NCT03546842 | Merck Sharp & Dohme LLC | Phase 3 |
| Terminated | A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital NCT03158974 | ViroXis Corporation | Phase 2 |
| Unknown | Safety and Efficacy of Immune Therapy for Condyloma NCT03158480 | Shenzhen Second People's Hospital | N/A |
| Recruiting | Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma NCT02520986 | Zydolab - Institute of Cytology and Immune Cytochemistry | N/A |
| Unknown | Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine NCT02710851 | Jun Zhang | Phase 2 |
| Completed | Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) NCT02535104 | Tamir Biotechnology, Inc. | Phase 1 / Phase 2 |
| Completed | Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine NCT02405520 | Jun Zhang | Phase 1 |
| Completed | Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs) NCT01796821 | G&E Herbal Biotechnology Co., LTD | Phase 2 |
| Completed | Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population NCT01598779 | University of Buenos Aires | — |
| Completed | Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts NCT01532102 | Anaconda Pharma | Phase 1 / Phase 2 |
| Unknown | Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile NCT01483794 | Universidad de Valparaiso | — |
| Completed | Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands NCT00973856 | Cleveland Clinic Akron General | N/A |
| Withdrawn | Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) NCT00365443 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Me NCT00090285 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts NCT00449982 | MediGene | Phase 3 |
| Completed | A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts NCT02015260 | University of Aberdeen | Phase 2 |